Related Experiment Videos

[Indications for ligation of ductus arteriosus Botalli persistens in premature infants]

Langenbecks Archiv Fur Chirurgie
|January 1, 1986
PubMed

Insights

Surgical ligation of patent ductus arteriosus is a safe, life-saving procedure for premature infants. Medical treatment with prostaglandin inhibitors is an alternative in select cases, with varying outcomes.

Area of Science:

  • Neonatal surgery
  • Pediatric cardiology
  • Pharmacology

Context:

  • Patent ductus arteriosus (PDA) is a common condition in premature infants.
  • PDA can lead to significant cardiorespiratory complications.
  • Treatment options for PDA include medical management and surgical intervention.

Purpose:

  • To evaluate the safety and efficacy of surgical ligation for PDA in premature infants.
  • To compare outcomes of medical treatment (prostaglandin inhibitors) versus surgical intervention.
  • To analyze mortality rates associated with different PDA treatment strategies.

Summary:

  • A study of 215 premature infants treated for PDA between 1976-1985.
  • 52 infants experienced spontaneous closure, 68 had closure after indomethacin treatment.
  • 48 infants underwent surgery after medical therapy failure, and 53 were primarily operated due to contraindications to indomethacin.
  • Overall mortality was 20%, highest in patients receiving combined medical and surgical treatment.

Impact:

  • Surgical ligation of PDA is a viable and potentially life-saving option for premature infants.
  • Medical management with prostaglandin inhibitors can be effective in selected cases.
  • Combined medical and surgical approaches may be associated with higher mortality, necessitating careful treatment selection.

Related Concept Videos